Overview

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).
Phase:
Phase 2
Details
Lead Sponsor:
Mati Therapeutics Inc.
Collaborator:
QLT Inc.
Treatments:
Latanoprost